Search results

117 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC tapped to lead national effort to find a cure for AIDS
Researchers at the University of North Carolina at Chapel Hill have been awarded a $32 million, five-year federal grant to develop ways to cure people with HIV by purging the virus hiding in the immune systems of patients taking antiretroviral therapy. Tackling this latent virus is considered key to a cure for AIDS.
Located in News / 2011 / July
As HIV treatment improves, 'trial effect' is diminished, new study suggests
A new study by investigators from the University of North Carolina at Chapel Hill School of Medicine has confirmed the existence of a “trial effect” in clinical trials for treatment of HIV and also shows that effect has diminished over time.
Located in News / 2011 / July
New findings from University of North Carolina-led HIV prevention study, HPTN 052
UNC researchers presented detailed data from the landmark HIV Prevention Trials Network (HPTN) 052 study today at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.
Located in News / 2011 / July
UNC receives NIH grant to develop and test new drugs to block HIV infection
Scientists at the University of North Carolina at Chapel Hill schools of medicine and pharmacy have been awarded a $3 million federal grant to develop and test a new generation of treatments aimed at preventing sexual transmission of HIV to uninfected individuals. This remains the most common cause of HIV infection worldwide.
Located in News / 2011 / July
UNC CFAR federal funding extended through 2016
The UNC Center for AIDS Research (CFAR) plays an active role in education and outreach, and provides developmental grant awards to support new ideas and new investigators in HIV/AIDS research.
Located in News / 2011 / September
New study adds further guidance on when to start antiretroviral therapy for HIV
A new study led by researchers at the University of North Carolina at Chapel Hill finds that there may be a limit to how early the therapy, known as HAART, should start.
Located in News / 2011 / September
Distinct AIDS viruses found in cerebrospinal fluid of people with HIV dementia
This is the first study to demonstrate active replication of HIV virus in a cell type other than immune T cells and which may help to predict patients at greatest risk for HIV dementia.
Located in News / 2011 / October
UNC tapped as training center for the state’s HIV health care providers
The University of North Carolina at Chapel Hill School of Medicine has been selected as the new home of the North Carolina AIDS Training and Education Center.
Located in News / 2011 / November
Cohen receives 2011 Hope is a Vaccine Award for contributions to HIV prevention research
Myron Cohen, MD, J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Public Health, has received the GAIA Vaccine Foundation’s 2011 Hope is a Vaccine Award.
Located in News / 2011 / December
When prophecy fails: How to better predict success in HIV prevention clinical trials
New research from the University of North Carolina at Chapel Hill schools of medicine and pharmacy may help explain the failure of some recent clinical trials of prevention of HIV infection, compared to the success of others that used the same drugs.
Located in News / 2011 / December